Li J - Search Results

1

Efficacy of apheresis platelets treated with riboflavin and ultraviolet light for pathogen reduction.

AuBuchon JP, Herschel L, Roger J, Taylor H, Whitley P, Li J, Edrich R, Goodrich RP. AuBuchon JP, et al. Among authors: li j. Transfusion. 2005 Aug;45(8):1335-41. doi: 10.1111/j.1537-2995.2005.00202.x. Transfusion. 2005. PMID: 16078923 Clinical Trial.

2

Evaluation of platelet mitochondria integrity after treatment with Mirasol pathogen reduction technology.

Li J, Lockerbie O, de Korte D, Rice J, McLean R, Goodrich RP. Li J, et al. Transfusion. 2005 Jun;45(6):920-6. doi: 10.1111/j.1537-2995.2005.04381.x. Transfusion. 2005. PMID: 15934990

3

Platelet glycolytic flux increases stimulated by ultraviolet-induced stress is not the direct cause of platelet morphology and activation changes: possible implications for the role of glucose in platelet storage.

Li J, Goodrich L, Hansen E, Edrich R, Gampp D, Goodrich RP. Li J, et al. Transfusion. 2005 Nov;45(11):1750-8. doi: 10.1111/j.1537-2995.2005.00582.x. Transfusion. 2005. PMID: 16271100

4

Toxicity testing of a novel riboflavin-based technology for pathogen reduction and white blood cell inactivation.

Reddy HL, Dayan AD, Cavagnaro J, Gad S, Li J, Goodrich RP. Reddy HL, et al. Among authors: li j. Transfus Med Rev. 2008 Apr;22(2):133-53. doi: 10.1016/j.tmrv.2007.12.003. Transfus Med Rev. 2008. PMID: 18353253 Review.

5

Functional inactivation of white blood cells by Mirasol treatment.

Fast LD, Dileone G, Li J, Goodrich R. Fast LD, et al. Among authors: li j. Transfusion. 2006 Apr;46(4):642-8. doi: 10.1111/j.1537-2995.2006.00777.x. Transfusion. 2006. PMID: 16584442

6

The Mirasol PRT system for pathogen reduction of platelets and plasma: an overview of current status and future trends.

Goodrich RP, Edrich RA, Li J, Seghatchian J. Goodrich RP, et al. Among authors: li j. Transfus Apher Sci. 2006 Aug;35(1):5-17. doi: 10.1016/j.transci.2006.01.007. Epub 2006 Aug 28. Transfus Apher Sci. 2006. PMID: 16935562 Review.

7

Mirasol PRT treatment of donor white blood cells prevents the development of xenogeneic graft-versus-host disease in Rag2-/-gamma c-/- double knockout mice.

Fast LD, DiLeone G, Cardarelli G, Li J, Goodrich R. Fast LD, et al. Among authors: li j. Transfusion. 2006 Sep;46(9):1553-60. doi: 10.1111/j.1537-2995.2006.00939.x. Transfusion. 2006. PMID: 16965583

8

Effects of a new pathogen-reduction technology (Mirasol PRT) on functional aspects of platelet concentrates.

Perez-Pujol S, Tonda R, Lozano M, Fuste B, Lopez-Vilchez I, Galan AM, Li J, Goodrich R, Escolar G. Perez-Pujol S, et al. Among authors: li j. Transfusion. 2005 Jun;45(6):911-9. doi: 10.1111/j.1537-2995.2005.04350.x. Transfusion. 2005. PMID: 15934989

9

Pathogen reduction of buffy coat platelet concentrates using riboflavin and light: comparisons with pathogen-reduction technology-treated apheresis platelet products.

Li J, de Korte D, Woolum MD, Ruane PH, Keil SD, Lockerbie O, McLean R, Goodrich RP. Li J, et al. Vox Sang. 2004 Aug;87(2):82-90. doi: 10.1111/j.1423-0410.2004.00548.x. Vox Sang. 2004. PMID: 15355498

10

Correlation of in vitro platelet quality measurements with in vivo platelet viability in human subjects.

Goodrich RP, Li J, Pieters H, Crookes R, Roodt J, Heyns Adu P. Goodrich RP, et al. Among authors: li j. Vox Sang. 2006 May;90(4):279-85. doi: 10.1111/j.1423-0410.2006.00761.x. Vox Sang. 2006. PMID: 16635070

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

190,832 results

Search Page

Filters